COEPTIS raises additional $5.7M in funding to accelerate company innovation, automation
Wexford-based COEPTIS, a biopharmaceutical and technology company focused on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, recently closed on an additio...
Read More